Request Information
Clinical Handbook of Psychotropic Drugs for Children and Adolescents
- Publication Year:
- 2018
- Edition:
- 4th Ed.
- Author:
- Elbe, Dean; Black, Tyler R.; McGrane, Ian R.; Procyshyn, Ric M.
- Publisher:
- Hogrefe Publishing GmbH
- ISBN:
- 978-0-88-937550-5
- Doody's Star Rating®:
- Score:
- 89
-
Description
-
Details
-
Collections
Description
Quick and comprehensive information on psychotropic drugs for children and adolescents.
The Clinical Handbook of Psychotropic Drugs for Children and Adolescents has become a standard reference and working tool for psychiatrists, pediatricians, psychologists, physicians, pharmacists, nurses, and other mental health professionals.
The Clinical Handbook of Psychotropic Drugs for Children and Adolescents has become a standard reference and working tool for psychiatrists, pediatricians, psychologists, physicians, pharmacists, nurses, and other mental health professionals.
- Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions…) for a quick overview of treatment options
- Succinct, bulleted information on all classes of medication: on- and off-label indications, side effects, interactions, pharmacodynamics, nursing implications, and much more – all you need to know for each class of drug
- Potential interactions and side effects summarized in comparison charts
- With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek
- Clearly written patient and caregiver information sheets
This book is a must for all mental health professionals working with children and adolescents who need an up-to-date, easy-to use, comprehensive summary of all the most relevant information about psychotropic drugs.
New in this edition:
- Drugs for ADHD thoroughly revised and updated
- Antipsychotics with many changes and additions, including fully revised lab tests/monitoring
- Antidepressants fully revised, including new sections on irreversible MAO-B inhibitor and serotonin modulator and stimulator (SMS), revised frequency of adverse effects table and switching strategies recommendations
- Hypnotics completely revised
- Mood stabilizers fully revised and a new toxicity comparison table added
- Drugs of abuse and treatment of substance use disorders comprehensively revised
- New unapproved treatments with significant updates, including: anti-inflammatories and NMDA agents in anxiety/OCD, cannabis use disorder, and irritability of autism
- New agents include: Third generation antipsychotics brexpiprazole and cariprazine, orexin receptor antagonist suvorexant, selective melatonin agonist tasimelteon, serotonin modulator and stimulator vortioxetine
- New formulations and trade names include: Adasuve, Alprazolam Intensol, Aptensio XR, Aristada, Belbuca, Belsomra, Brintellix, Bunavail, Cotempla XR-ODT, Dyanavel XR, Eldepryl, EMSAM, Evekeo, Hemangeol, Hetlioz, Innopran XL, Invega Trinza, Khedezla, Metadol-D, Mydayis, NyQuil, Quillichew ER, Quillivant XR, Rexulti, Tegretol (liquid), Trintellix, Versacloz, Vraylar, Zelapar, Zenzedi
Details
- Platform:
- OvidSP
- Publisher:
- Hogrefe Publishing GmbH
- Product Type:
- Book
- Author:
- Elbe, Dean; Black, Tyler R.; McGrane, Ian R.; Procyshyn, Ric M.
- ISBN:
- 978-0-88-937550-5
- Specialty:
-
- Addiction Disorder
- Pediatrics
- Psychology
- Substance Abuse
- Language:
- English
- Edition:
- 4th Ed.
- Pages:
- 396
- Publication Year:
- 2018
- Doody's Star Rating®:
- Score:
- 89